miR-17-92a-1 cluster host gene: a key regulator in colorectal cancer development and progression

Colorectal cancer (CRC), recognized among the five most prevalent malignancies and most deadly cancers, manifests multifactorial influences stemming from environmental exposures, dietary patterns, age, and genetic predisposition. Although substantial progress has been made in comprehending the etiol...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and experimental medicine 2024-04, Vol.24 (1), p.85-85, Article 85
Main Authors: Mohajeri Khorasani, Amirhossein, Mohammadi, Samane, Raghibi, Alireza, Haj Mohammad Hassani, Behzad, Bazghandi, Behina, Mousavi, Pegah
Format: Article
Language:English
Subjects:
Cell Proliferation
Colorectal Neoplasms - genetics
Colorectal Neoplasms - pathology
Disease Progression
Gene Expression Regulation, Neoplastic
Hematology
Humans
Internal Medicine
Medicine
Medicine & Public Health
MicroRNAs - genetics
MicroRNAs - metabolism
Multigene Family
Oncology
Review
RNA, Long Noncoding - genetics
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Colorectal cancer (CRC), recognized among the five most prevalent malignancies and most deadly cancers, manifests multifactorial influences stemming from environmental exposures, dietary patterns, age, and genetic predisposition. Although substantial progress has been made in comprehending the etiology of CRC, the precise genetic components driving its pathogenesis remain incompletely elucidated. Within the expansive repertoire of non-coding RNAs, particular focus has centered on the miR-17-92a-1 cluster host gene (MIR17HG) and its associated miRNAs, which actively participate in diverse cellular processes and frequently exhibit heightened expression in various solid tumors, notably CRC. Therefore, the primary objective of this research is to undertake an extensive inquiry into the regulatory mechanisms, structural features, functional attributes, and potential diagnostic and therapeutic implications associated with this cluster in CRC. Furthermore, the intricate interplay between this cluster and the development and progression of CRC will be explored. Our findings underscore the upregulation of the miR-17-92a-1 cluster host gene (MIR17HG) and its associated miRNAs in CRC compared to normal tissues, thus implying their profound involvement in the progression of CRC. Collectively, these molecules are implicated in critical oncogenic processes, encompassing metastatic activity, regulation of apoptotic pathways, cellular proliferation, and drug resistance. Consequently, these findings shed illuminating insights into the potential of MIR17HG and its associated miRNAs as promising targets for therapeutic interventions in the management of CRC. Graphical abstract
ISSN:1591-9528
1591-9528
DOI:10.1007/s10238-024-01331-1